Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 6/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 1/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.39 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20104531 | 0.76 | CCNB2 (0.50) | CNR1CNR2CCNB2CDK1CCNB1 | |
| SCHEMBL11619004 | 0.73 | CCNB2 (0.53) | CNR1CNR2CCNB2CDK1CCNB1 | |
| SCHEMBL17540778 | 0.72 | CNR1 (0.49) | CNR1CNR2CCNB2CDK1CCNB1 | |
| SCHEMBL28975523 | 0.71 | OPRM1 (0.41) | — | |
| SCHEMBL28979017 | 0.71 | OPRM1 (0.41) | — | |
| Carbazole SCHEMBL27757289 | 0.68 | ALDH1A1 (0.67) | — | |
| SCHEMBL12244367 | 0.67 | CCNB2 (0.75) | CNR1CNR2CCNB2CDK1CCNB1 | |
| SCHEMBL11659899 | 0.67 | CNR1 (0.63) | CNR1CNR2CCNB2CDK1CCNB1 | |
| SCHEMBL17540738 | 0.67 | CNR1 (0.74) | CNR1CNR2 | |
| Tetradecane SCHEMBL9931701 | 0.67 | ALDH1A1 (0.64) | HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2018-05-03 | — | — | US | disclosed |
| WO-2016029310-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118681-A1 | CANNABINOID TYPE 1 RECEPTOR MODULATORS | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885CCNB2 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.